Show Me
Exercise for heart health in prostate cancer.
Published August 20, 2018
Everyday more than 45 men are diagnosed with prostate cancer in Australia. Androgen deprivation therapy (ADT) is an efficacious anti-cancer therapy that reduces prostate cancer mortality. However, ADT may increase the risk of cardiovascular morbidity and mortality. Improvements in prostate cancer treatment means that patients are living long enough to experience the late effects associated with ADT. Thus, cardiovascular disease is a significant issue faced by many men with prostate cancer. Against this background, there is a plethora of evidence in the cardiovascular medicine that may highlight the potential mechanisms contributing to cardiovascular disease, key diagnostic methods to identify those at the highest risk and the potential efficacy of exercise medicine to modify cardiovascular risk. The purpose of this pilot research study is to evaluate the impact of ADT on cardiovascular structure and function, as well as the impact of exercise training during ADT on cardiovascular structure and function.
Who is this trial for?
What does participation involve?
Where are the exercise clinics?
How do I get involved?
Register your interest to participate in the trial
Level 5, 215 Spring Street,
Melbourne, VIC, 3000
Chat with our team via social media.